Buys
Open market- Shares
- +802
- Avg price
- $3.75
- Total value
- +$3,007
A. J. Kazimi - Chairman and CEO, Director, 10%+ Owner at CUMBERLAND PHARMACEUTICALS INC
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Chairman and CEO, Director, 10%+ Owner
- Issuer Symbol
- CPIX on Nasdaq
- All Insider Reports
- All Insider Reports
A. J. Kazimi - trading volume in the past year for CUMBERLAND PHARMACEUTICALS INC
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +802
- Share %
- 100%
- Total value
- +$3,007
Holdings reported by A. J. Kazimi for CUMBERLAND PHARMACEUTICALS INC
Form 4 holding
Chairman and CEO, Director, 10%+ Owner
CUMBERLAND PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 5,695,310
- Estimated value
- $25,514,988
- Report date
- 16 Mar 2026
- Price
- $4.48
- Ownership
- Direct
Form 4 holding
Chairman and CEO, Director, 10%+ Owner
CUMBERLAND PHARMACEUTICALS INC
- Security class
- Options (right to buy)
- Shares / value
- 568,000
- Estimated value
- $2,419,560
- Report date
- 18 Mar 2026
- Price
- $5.17
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by A. J. Kazimi for CUMBERLAND PHARMACEUTICALS INC
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.